Tandem Diabetes Care, Inc.
TNDM
NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.5B
$21.67
▲ +1.12%
P/E
-23.33
Mkt Cap
$1.5B
52-Wk Range
$11.46–$29.65
52-Week Range
$11.46 - $29.65
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 67.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Advanced AI-powered insulin delivery algorithms (Basal-IQ, Control IQ) reducing hypoglycemic events
- Integrated ecosystem connecting pumps, CGM, and digital platforms for seamless data flow
- Strategic partnerships with Dexcom and Abbott providing competitive moat in device interoperability
- Strong brand loyalty and user satisfaction in insulin pump market
- Recurring revenue model through consumable cartridges and infusion sets
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Stable outlook
Expanding global market penetration beyond United States into international markets
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+24.6% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying TNDM right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 6, 2026
Reported EPS of -$0.31 vs -$0.32 consensus (+3.4% surprise). Revenue of $254.6M vs $255.0M expected (-0.2%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.4%
Revenue trend · last 8Q
—
+44%
+22%
+8%
-31%
+3%
+5%
+6%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$363.3M
$282.6M
$234.4M
$240.7M
$249.3M
$290.4M
$247.2M
$254.6M
Margins · last 8Q
Gross
56.9%
Operating
-5.4%
Profit
-8.3%
Wall Street consensus
11 analysts · 64% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
64%
Hold
36%
Sell
0%
Median Price Target
—
Latest: William Blair · Aug 21, 2026
vs Industry
How TNDM stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related